Other specified and unspecified disorders of lens

H7_DISORDERLENSNAS

lens disease: A disease involving the lens of camera-type eye. [database_cross_reference: MONDO:DesignPattern]

Suggest a new description

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 H27.8, H27.9
  • Hospital discharge: ICD-9 3793X
  • Cause of death: ICD-10 H27.8, H27.9
  • Cause of death: ICD-9 3793X

2 out of 7 registries used, show all original rules.

309

4. Check minimum number of events

None

309

5. Include endpoints

None

309

6. Filter based on genotype QC (FinnGen only)

309

Control definitions (FinnGen only)

Control exclude
H7_LENS

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2266 1677 581
Only index persons 2126 1584 542
Unadjusted period prevalence (%)
Whole population 0.04 0.05 0.02
Only index persons 0.05 0.06 0.02
Median age at first event (years)
Whole population 76.62 76.97 75.56
Only index persons 76.59 76.93 75.59

-FinnGen-

Key figures

All Female Male
Number of individuals 309 216 93
Unadjusted period prevalence (%) 0.06 0.07 0.04
Median age at first event (years) 73.94 73.68 74.55

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
276
Matched controls
2758
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H27.8
ICD-10 Finland
Other specified disorders of lens
10310.7
323.0
266
*
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
364.6
244.4
220
29
H25.1
ICD-10 Finland
Senile nuclear cataract
116.3
142.9
148
27
H25.8
ICD-10 Finland
Other senile cataract
311.9
117.8
112
6
Z96.1
ICD-10 Finland
Presence of intraocular lens
35.7
87.5
115
54
WX100
NOMESCO Finland
Conjunctival surface anesthesia
50.9
62.9
75
20
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
9.1
61.7
182
482
H26.4
ICD-10 Finland
After-cataract
144.6
46.4
48
*
H40.0
ICD-10 Finland
Glaucoma suspect
10.9
40.8
84
106
CJB10
NOMESCO Finland
Laser discission of secondary cataract
61.6
36.6
42
8
H40.10
ICD-10 Finland
Capsular glaucoma with pseudoexfoliation on the anterior lens capsule
19.8
31.6
48
29
S01ED51
ATC
timolol, combinations; ophthalmic
7.5
22.5
56
91
H25.0
ICD-10 Finland
Senile incipient cataract
12.8
19.1
34
30
114
Kela drug reimbursment
Glaucoma
5.3
17.6
58
133
CHD00
NOMESCO Finland
Laser trabeculoplasty
22.8
17.6
25
12
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
17.8
16.9
26
16
WX140
NOMESCO Finland
Parabulbar anesthesy
12.3
15.1
27
24
CKD60
NOMESCO Finland
Anterior vitrectomy
+∞
14.7
14
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.7
14.3
157
899
S01EE01
ATC
latanoprost; ophthalmic
5.7
14.3
42
84
SPAT1263
SPAT
Sampling
2.7
14.0
146
809
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
6.2
13.9
38
69
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
6.0
13.8
39
74
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.6
13.2
157
927
H35.30
ICD-10 Finland
Kuhnt-Junius degeneration
6.4
12.2
32
55
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
3.6
12.1
60
200
SPAT1312
SPAT
General health counselling
2.6
11.6
109
552
H52.2
ICD-10 Finland
Astigmatism
36.7
11.4
14
*
H04.10
ICD-10 Finland
Dry eye syndrome
4.2
11.0
43
116
CHC05
NOMESCO Finland
Iridotomy
19.7
10.4
15
8
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.7
10.3
81
367
H27.1
ICD-10 Finland
Dislocation of lens
+∞
9.4
9
*
AA1AD
NOMESCO Finland
CT of head and brain
2.4
9.4
97
507
XCK00
NOMESCO Finland
Perimetry
4.6
9.4
32
76
WX110
NOMESCO Finland
Local anesthesy
2.2
9.3
175
1208
H52.0
ICD-10 Finland
Hypermetropia
20.8
8.5
12
6
S01EA05
ATC
brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)
8.3
8.5
18
23
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.4
8.5
80
395
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
4.9
8.5
27
60
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
4.6
8.1
27
63
WX002
NOMESCO Finland
Sedation and analgesia
2.5
7.9
66
305
E0000UV
ATC
NA
2.1
7.9
119
726
SPAT1256
SPAT
Intramuscular and subcutaneous injection
2.1
7.9
135
871
S01EC04
ATC
brinzolamide; ophthalmic
5.5
7.7
22
43
XCH00
NOMESCO Finland
Eye pressure measurement
8.7
7.4
15
18
CHD05
NOMESCO Finland
Selective lasertrabeculoplasty
6.6
7.4
18
29
H27.9
ICD-10 Finland
Disorder of lens, unspecified
+∞
7.3
7
*
H52.1
ICD-10 Finland
Myopia
12.5
7.1
12
10
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.0
7.1
132
867
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.2
7.0
35
118
H35.39
ICD-10 Finland
Degeneration of macula and posterior pole
8.6
6.9
14
17
SPAT1325
SPAT
Vaccination
2.0
6.8
128
839
T85.2
ICD-10 Finland
Mechanical complication of intraocular lens
41.1
6.8
8
*
NF1AA
NOMESCO Finland
Hip X-ray examination
2.8
6.6
44
177
WX720
NOMESCO Finland
Own respiration
4.9
6.6
20
43
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
71.4
6.5
7
*
P20
ICPC
Memory disturbance
2.3
6.4
64
322
WX320
NOMESCO Finland
Spinalanesthesy
2.1
6.4
77
421
H53.1
ICD-10 Finland
Subjective visual disturbances
3.9
6.4
25
69
SPAT1153
SPAT
Removal of sutures
2.0
6.3
107
669
SPAT1254
SPAT
Administration of medicine
2.3
6.3
61
303
SPAT1310
SPAT
Counselling related to known health issue
2.0
6.1
100
614
A98
ICPC
Health maint/preventive medicine
2.5
6.1
247
2136

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
122
273
6.73
56.44
5.3
4.7
%
37.1
34.5
1.04
59
157
(3019225) pH of Specimen
106
246
6.04
46.24
3.7
4.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
216
1177
3.77
26.37
2.7
2.1
pmol/l
113.5
95.0
2.79
100
539
(3019309) Folate [Moles/volume] in Red Blood Cells
139
617
3.28
22.86
1.9
1.7
nmol/l
857.7
1177.6
5.57
96
451
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
205
1176
3.21
21.06
3.8
2.8
u/l
46.1
50.9
0.30
175
1058
(3013512) EKG study
151
747
3.00
19.93
5.5
4.4
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
208
1241
3.07
19.21
5.6
5.3
mmol/l
1.2
1.2
0.48
163
1118
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
46
110
4.74
18.37
2.2
2.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
44
103
4.82
18.02
2.2
1.8
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
185
1100
2.70
16.08
11.8
9.8
inr
1.2
1.4
1.08
19
283
(3013707) Erythrocyte sedimentation rate by Westergren method
247
1709
3.22
15.95
5.2
3.9
mm/h
15.3
15.8
0.18
208
1555
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
212
1364
2.77
15.49
7.0
6.0
mmol/l
1.2
1.2
0.96
168
1150
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
278
2083
4.34
15.42
6.4
5.1
mu/l
2.1
2.0
0.21
223
1869
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
285
2185
4.92
15.00
6.2
5.3
mmol/l
2.4
2.6
3.48
228
1958
(42870588) Differential panel, method unspecified - Blood
142
761
2.60
14.99
5.9
4.5
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
285
2193
4.86
14.73
6.6
5.0
mmol/l
6.0
6.1
0.51
230
1952
(3037467) Urinalysis macro (dipstick) panel - Urine
240
1674
2.94
14.48
7.3
4.8
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
278
2114
4.14
14.37
5.4
4.6
mmol/l
4.4
4.5
0.81
226
1903
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
133
704
2.56
14.25
2.6
2.2
u/l
54.7
55.1
0.07
115
642
(3013826) Glucose [Moles/volume] in Serum or Plasma
215
1434
2.64
13.90
5.8
4.6
mmol/l
6.9
6.8
0.21
208
1336
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
164
969
2.48
13.72
4.9
3.9
ng/l
33.2
79.1
0.77
134
740
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
294
2352
6.15
13.56
13.6
10.4
u/l
21.6
22.4
0.71
269
2252
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
138
759
2.48
13.44
2.2
1.9
u/l
122.1
319.4
1.23
128
697
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
252
1842
3.00
13.20
8.4
6.9
u/l
78.4
80.4
0.27
224
1703
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
274
2102
3.68
13.13
5.9
4.6
mmol/l
1.6
1.5
2.36
218
1883
(3018010) Neutrophils/100 leukocytes in Blood
172
1059
2.41
12.86
5.8
5.0
%
59.8
58.7
0.51
144
974
(3019069) Monocytes/100 leukocytes in Blood
172
1060
2.40
12.82
6.5
5.2
%
8.8
8.8
0.01
148
976
(3022313) Gas panel - Capillary blood
37
99
4.11
12.70
2.2
4.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
273
2109
3.53
12.51
8.1
6.4
mmol/mol
41.1
40.7
0.23
220
1921
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
267
2038
3.28
12.46
4.7
4.0
mmol/l
1.1
1.2
1.88
207
1800
(3021960) Folate [Moles/volume] in Serum or Plasma
126
686
2.41
12.32
1.9
1.6
nmol/l
20.0
21.4
0.38
91
572
(3017732) Neutrophils [#/volume] in Blood
43
131
3.65
12.30
2.4
3.4
e9/l
4.2
4.0
0.08
22
85
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
125
680
2.41
12.23
2.4
2.1
mg/l
3.0
3.2
0.34
97
561
(3002030) Lymphocytes/100 leukocytes in Blood
172
1076
2.35
12.17
6.2
5.1
%
25.0
26.2
0.80
144
982
(40761511) CBC panel - Blood by Automated count
286
2287
4.37
12.15
23.9
15.2
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
194
1280
2.39
12.10
6.2
5.5
umol/l
10.9
11.6
0.74
178
1205
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
74
316
2.76
11.97
5.3
7.3
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
293
2393
5.33
11.84
26.7
19.6
mmol/l
139.2
139.5
0.86
282
2334
(3023103) Potassium [Moles/volume] in Serum or Plasma
293
2395
5.31
11.78
26.8
19.7
mmol/l
4.0
4.0
0.04
282
2332
(3006504) Eosinophils/100 leukocytes in Blood
168
1052
2.31
11.71
6.1
4.9
%
2.5
2.7
0.65
144
962
(36660697) Celiac disease serology panel - Serum
47
158
3.33
11.54
1.2
1.1
—
—
—
0
0
(4146454)
16
21
7.98
11.53
2.5
3.0
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
295
2433
5.69
11.50
32.5
23.8
e9/l
247.5
246.1
0.12
288
2351
(3024731) MCV [Entitic volume]
295
2433
5.69
11.50
32.4
23.7
fl
91.7
91.7
0.09
289
2379
(3000963) Hemoglobin [Mass/volume] in Blood
295
2434
5.68
11.47
32.8
23.9
g/l
128.4
130.0
1.14
289
2382
(3026361) Erythrocytes [#/volume] in Blood
295
2434
5.68
11.47
32.5
23.8
e12/l
4.3
4.3
1.56
287
2344
(3035941) MCH [Entitic mass]
295
2434
5.68
11.47
32.4
23.7
pg
30.4
30.3
0.29
289
2381
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
41
127
3.57
11.42
2.2
4.5
mmol/l
2.1
2.1
0.02
35
97
(3010813) Leukocytes [#/volume] in Blood
295
2436
5.66
11.41
32.7
23.8
e9/l
6.9
6.8
0.10
288
2344
(3001122) Ferritin [Mass/volume] in Serum or Plasma
147
886
2.26
11.05
3.0
2.7
ug/l
135.5
138.1
0.05
123
787
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
281
2258
3.70
11.04
21.2
16.0
mg/l
22.3
29.0
2.69
249
1832
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
94
475
2.41
10.61
2.5
1.7
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
20
37
5.71
10.54
2.7
2.2
mg/l
28.3
40.3
—
6
9
(3009542) Hematocrit [Volume Fraction] of Blood
251
1916
2.65
10.50
24.4
19.1
%
33.9
37.5
2.02
106
1185
(3013115) Eosinophils [#/volume] in Blood
174
1145
2.19
10.27
5.7
4.9
e9/l
0.2
0.2
0.04
148
959
(3022096) Basophils/100 leukocytes in Blood
161
1029
2.18
10.22
6.2
4.9
%
0.6
0.7
0.15
137
945
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
231
1721
2.36
9.81
4.6
4.1
pmol/l
15.2
15.4
0.33
178
1537
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
111
625
2.21
9.57
2.5
2.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
159
1030
2.12
9.54
2.6
2.2
nmol/l
83.8
82.6
0.17
116
886
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
26
67
4.15
9.34
3.7
2.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
152
975
2.10
9.29
2.7
2.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
143
899
2.10
9.20
3.6
3.0
ng/l
2328.8
1935.7
0.29
106
780
(3006315) Basophils [#/volume] in Blood
165
1111
2.04
8.64
5.6
4.8
e9/l
0.0
0.0
0.18
143
920
(3001604) Monocytes [#/volume] in Blood
164
1105
2.03
8.54
5.6
4.7
e9/l
0.6
0.6
0.97
140
914
(3019198) Lymphocytes [#/volume] in Blood
166
1130
2.01
8.33
5.7
4.8
e9/l
1.7
1.8
1.46
144
955
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
14
23
6.33
8.25
2.0
2.2
—
—
—
0
0
(4010399)
38
141
2.93
7.85
1.4
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
118
725
2.02
7.78
3.4
3.1
mg/l
818.3
381.0
0.23
54
459
(3009508) Creatinine [Moles/volume] in Urine
117
727
1.98
7.40
3.4
3.0
mmol/l
6.0
6.3
0.55
79
603
(3020682) Albumin/Creatinine [Ratio] in Urine
122
777
1.94
7.13
4.0
3.9
mg/mmol
3.7
10.2
2.07
58
483
(4024509)
12
20
6.20
6.95
2.3
1.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
12
20
6.20
6.95
1.2
1.7
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
12
20
6.20
6.95
1.2
1.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
43
183
2.57
6.84
1.5
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
19
50
3.98
6.64
1.8
1.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
96
575
1.97
6.63
1.5
1.7
pmol/l
534.5
431.1
2.10
71
457
(3005570) Glucose [Moles/volume] in Urine
15
33
4.73
6.53
2.6
1.7
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
158
1121
1.84
6.42
4.2
3.7
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
178
1332
1.79
5.87
8.6
7.9
e9/l
4.4
4.2
0.58
148
1126
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
57
294
2.15
5.85
6.3
2.9
ng/l
346.7
232.7
0.41
52
274
(3023520) Reticulocytes [#/volume] in Blood
49
238
2.26
5.82
2.5
2.4
e9/l
74.8
68.7
0.59
44
182
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
16
41
4.06
5.79
1.4
1.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
61
327
2.08
5.66
2.7
2.3
%
1.9
1.8
0.48
50
298
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
32
130
2.63
5.58
6.4
8.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
10
18
5.71
5.35
1.3
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
15
39
3.99
5.33
1.5
1.6
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
56
298
2.07
5.28
4.3
3.9
u/l
256.6
266.4
0.15
47
281
(3025941) Bacteria identified in Stool by Culture
22
75
3.08
5.26
1.3
1.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
143
1028
1.73
5.22
4.2
3.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
42
202
2.25
5.10
2.1
1.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
134
951
1.72
5.09
2.5
2.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
119
818
1.74
5.06
2.7
2.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
10
20
5.13
4.81
3.7
2.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
65
1020
0.54
4.65
13.6
9.2
e9/l
0.0
0.0
0.53
49
829
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
247
2108
1.86
4.56
18.2
16.3
ml/min/173m2
66.6
69.5
1.27
195
1721
(3023368) Bacteria identified in Blood by Culture
111
768
1.69
4.51
4.2
3.8
—
—
—
0
0
(3022145) Colonoscopy Study observation
45
235
2.07
4.45
1.2
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
85
549
1.76
4.41
3.2
2.8
umol/l
333.6
12924.6
4.27
59
450
(3019060) Gas panel - Arterial blood
34
163
2.22
4.16
3.1
3.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
16
52
3.19
4.14
1.5
1.4
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
132
972
1.63
4.14
2.5
3.2
mmol/l
2.4
2.4
0.33
83
822
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
30
137
2.32
4.11
2.5
2.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
45
244
1.99
4.02
1.4
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
76
494
1.71
3.81
1.6
1.6
mg/l
1.1
1.3
0.46
61
387
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
95
660
1.63
3.69
3.7
2.5
u/l
26.8
32.6
2.27
89
623
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
19
75
2.63
3.53
2.0
2.2
ug/l
217.5
1173.8
0.92
19
70
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
76
506
1.67
3.46
7.1
5.7
ug/l
8.4
3.0
0.64
67
433
(44790048)
9
18
5.12
3.39
1.7
1.4
—
—
—
0
0
(44806118)
9
18
5.12
3.39
1.7
1.4
—
—
—
0
0
(44790049)
9
18
5.12
3.39
1.7
1.4
—
—
—
0
0
(44790047)
9
18
5.12
3.39
1.7
1.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
6
7
8.71
3.27
1.0
2.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
6
7
8.71
3.27
1.0
2.0
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
37
203
1.93
3.20
2.4
1.8
ug/g
139.6
140.9
0.01
24
148
(3017704) Immunofixation for Urine
8
16
5.10
3.07
1.4
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
6
8
7.62
3.07
1.0
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
6
8
7.62
3.07
1.0
1.9
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
45
268
1.79
3.03
1.7
1.7
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
5
5
10.13
2.99
2.0
3.0
nmol/l
19.4
18.8
—
5
5
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
10
30
3.41
2.93
1.7
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
9
6.77
2.88
1.0
1.9
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
9
6.77
2.88
1.0
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
9
6.77
2.88
1.0
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
9
6.77
2.88
1.0
1.9
—
—
—
0
0
(40768443) Skin Pathology biopsy report
21
97
2.25
2.84
1.1
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
10
31
3.30
2.79
1.7
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
10
31
3.30
2.79
1.7
1.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
81
575
1.55
2.79
7.0
3.9
ng/l
609.9
248.6
0.28
71
500
(3024561) Albumin [Mass/volume] in Serum or Plasma
147
1181
1.47
2.79
5.5
4.0
g/l
34.3
34.5
0.16
132
1080
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
7
14
5.09
2.74
1.1
1.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
39
617
0.58
2.63
6.8
4.5
estimate
0.0
0.0
0.00
14
214
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
15
4.75
2.61
1.0
1.9
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
15
4.75
2.61
1.0
1.9
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
15
4.75
2.61
1.0
1.9
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
49
314
1.67
2.56
1.1
1.2
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
5
7
7.24
2.56
2.2
1.0
nmol/l
251.6
146.6
—
5
7
(3020191) Ethanol [Moles/volume] in Serum or Plasma
5
7
7.24
2.56
1.2
1.0
promille
2.0
0.8
—
5
7
(4015189)
5
7
7.24
2.56
4.4
3.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
8
21
3.88
2.48
1.4
1.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
51
334
1.63
2.45
1.8
1.8
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
12
5.07
2.41
1.2
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
80
584
1.50
2.40
1.8
1.6
mmol/l
1.0
1.3
3.37
67
486
(3008757) Leukocyte morphology finding [Identifier] in Blood
8
23
3.54
2.28
3.6
3.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
6
13
4.68
2.28
1.0
1.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
32
514
0.58
2.27
3.8
3.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
24
3.39
2.19
1.4
1.6
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
8
24
3.39
2.19
1.3
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
8
24
3.39
2.19
1.3
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
19
3.74
2.16
1.4
1.7
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
14
4.35
2.16
1.0
1.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
66
473
1.50
2.15
5.3
4.6
kg/l
1.0
1.0
0.11
14
61
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
40
255
1.65
2.14
2.4
3.1
ng/l
134.1
83.0
0.66
29
216
(36304419) Bacteria [Presence] in Urine
53
742
0.66
2.09
4.5
3.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
9
31
2.96
2.09
1.8
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
9
31
2.96
2.09
1.8
1.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
9
31
2.96
2.09
1.8
1.6
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
56
775
0.66
2.09
4.8
3.3
e6/l
0.5
0.7
0.25
46
571
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
58
408
1.52
2.06
6.1
4.8
%
22.2
21.1
0.20
27
218
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
18
90
2.06
2.05
2.2
4.4
—
3.3
—
0
8
(3051593) INR in Capillary blood by Coagulation assay
6
15
4.06
2.05
3.8
8.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
9
32
2.87
2.01
1.1
1.7
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
45
303
1.57
1.95
5.7
6.5
mmol/l
1.3
1.4
0.05
36
244
(3003458) Phosphate [Moles/volume] in Serum or Plasma
50
345
1.54
1.94
4.1
4.5
mmol/l
1.0
1.1
0.42
45
312
(3002582) Erythrocytes [#/volume] in Urine
63
841
0.68
1.93
4.5
3.2
e6/l
48.4
87.5
0.84
53
618
(3017143) Hepatitis C virus Ab [Presence] in Serum
24
137
1.82
1.89
1.5
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
35
223
1.64
1.89
1.2
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
28
2.91
1.87
1.3
1.7
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
12
4.22
1.83
1.2
1.2
—
—
—
0
0
(4211845)
5
12
4.22
1.83
6.2
4.3
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
12
4.22
1.83
6.2
4.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
23
3.09
1.81
2.1
1.9
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
24
140
1.77
1.78
2.5
1.8
g/l
1.8
1.7
0.05
18
121
(3037522) Nuclear Ab [Titer] in Serum
34
220
1.61
1.74
1.1
1.2
titre
530.0
436.4
—
8
45
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
7
24
2.96
1.73
1.3
1.3
miu/ml
—
236.5
—
0
7
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
13
3.89
1.72
1.0
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
13
3.89
1.72
1.0
1.0
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
5
13
3.89
1.72
1.4
1.0
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
54
390
1.47
1.70
3.0
2.4
g/l
2.4
2.3
0.64
44
353
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
17
90
1.94
1.68
1.0
1.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
14
69
2.08
1.67
1.2
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
17
91
1.92
1.64
1.2
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
41
282
1.52
1.63
1.7
1.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
50
360
1.46
1.60
1.2
1.5
g/l
2.6
2.3
0.25
16
167
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
26
2.73
1.59
1.4
1.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
7
26
2.73
1.59
4.4
3.7
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
20
3.04
1.59
1.0
2.0
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
47
635
0.69
1.51
3.0
2.9
mmol/l
2.5
2.5
0.11
40
556
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
21
2.89
1.51
1.2
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
12
58
2.11
1.51
1.2
1.5
—
—
—
0
0
(3000492) Spirometry study
25
156
1.66
1.49
1.8
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
25
156
1.66
1.49
1.4
1.4
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
54
401
1.42
1.48
3.3
2.7
mmol/l
0.8
0.8
0.15
40
363
(3051611) Lipemic interference index of Serum or Plasma
7
28
2.53
1.46
2.1
2.6
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
16
3.16
1.44
1.4
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
16
3.16
1.44
1.4
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
16
3.16
1.44
1.0
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
6
22
2.76
1.44
1.7
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
6
22
2.76
1.44
2.0
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
44
595
0.70
1.42
7.4
6.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
43
309
1.45
1.40
1.1
1.2
iu/ml
32.2
39.6
0.19
15
104
(3022948) Iron [Moles/volume] in Serum or Plasma
56
424
1.39
1.38
3.0
2.4
umol/l
11.2
12.0
0.32
48
383
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
41
296
1.44
1.31
1.1
1.2
u/ml
61.9
17.1
—
5
76
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
19
2.66
1.22
1.4
1.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
5
19
2.66
1.22
1.0
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
6
26
2.33
1.19
1.3
2.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
10
184
0.53
1.18
8.3
4.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
34
0.00
1.16
0.0
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
20
2.52
1.15
1.2
1.5
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
7
30
2.36
1.13
1.6
1.3
—
—
—
0
0
(1002224) Polysomnography panel
8
41
1.98
1.09
1.0
1.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
5
21
2.40
1.09
1.0
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
21
2.40
1.09
2.0
1.8
%
12.6
11.4
—
5
21
(3044889) 12 lead EKG panel
153
1694
0.81
1.07
5.1
4.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
48
371
1.35
1.06
3.0
2.5
%
19.5
21.1
0.32
31
318
(3018095) Leukocytes [#/volume] in Urine
81
960
0.79
1.05
5.1
3.7
e6/l
318.7
188.2
0.33
54
657
(3049717) Cytology report of Urine Cyto stain
17
106
1.64
1.05
2.6
3.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
26
181
1.48
1.02
4.0
3.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
5
23
2.19
0.98
1.2
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
7
36
1.97
0.97
1.0
1.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
44
341
1.34
0.96
2.6
1.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
14
85
1.68
0.96
1.9
2.0
u/ml
0.3
0.4
—
8
45
(3044290) Cell count panel - Cerebral spinal fluid
7
37
1.91
0.94
1.1
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
7
37
1.91
0.94
1.3
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
71
591
1.26
0.92
4.6
3.8
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
26
186
1.43
0.91
1.7
1.6
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
166
1804
0.83
0.89
29.3
20.7
%
14.0
13.9
0.43
161
1762
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
31
232
1.37
0.85
2.2
2.1
ug/l
18.2
6.9
0.48
15
191
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
31
1.95
0.85
1.5
1.1
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
82
948
0.82
0.83
4.5
3.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
13
81
1.63
0.82
1.2
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
20
139
1.47
0.81
1.5
1.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
40
498
0.77
0.77
3.4
2.9
e6/l
0.6
1.6
2.71
20
266
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
6
34
1.78
0.76
1.2
1.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
34
1.78
0.76
1.2
1.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
128
1153
1.19
0.76
4.9
4.0
estimate
0.0
0.0
0.00
14
230
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
24
2.10
0.75
1.4
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
24
2.10
0.75
1.0
1.0
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
14
92
1.55
0.73
1.0
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
40
1.77
0.71
1.1
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
5
26
1.94
0.71
1.4
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
7
41
1.72
0.70
1.0
1.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
20
144
1.42
0.70
3.7
3.1
g/l
10.2
10.8
0.23
20
125
(3037756) Immunofixation for Serum or Plasma
12
77
1.58
0.69
2.3
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
29
223
1.33
0.69
2.7
2.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
42
341
1.27
0.68
2.8
1.6
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
18
128
1.43
0.67
1.7
2.6
g/l
10.5
10.0
—
10
109
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
43
1.64
0.67
5.6
2.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
16
223
0.70
0.65
5.4
3.8
mmol/l
1.2
1.2
0.02
16
192
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
29
1.74
0.64
1.0
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
11
71
1.57
0.63
1.9
1.7
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
8
49
1.65
0.62
1.6
1.3
pmol/l
128.1
504.6
—
8
49
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
21
0.00
0.60
0.0
1.4
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
10
64
1.58
0.59
2.7
5.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
39
470
0.81
0.59
3.3
2.9
e6/l
2.2
4.2
1.18
19
243
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
8
53
1.52
0.59
1.0
1.8
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
11
161
0.67
0.58
3.3
3.2
ml/min/173m2
61.8
53.4
—
5
75
(3020891) Body temperature
5
88
0.56
0.57
5.6
3.9
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
8
55
1.47
0.56
1.3
1.5
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
18
133
1.38
0.56
1.7
2.6
g/l
6.5
7.6
—
8
101
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
18
133
1.38
0.56
1.7
2.5
g/l
3.9
3.5
—
8
98
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
18
133
1.38
0.56
1.7
2.6
—
—
—
0
0
(3002256) Pathology report gross observation
36
295
1.25
0.56
1.3
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
49
573
0.83
0.56
5.1
4.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
94
845
1.16
0.56
4.1
3.8
ph
7.4
7.4
—
9
141
(3014007) Fractional oxyhemoglobin in Arterial blood
10
147
0.67
0.55
11.9
9.7
%
95.0
94.6
—
10
147
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
39
1.55
0.53
1.2
1.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
21
268
0.77
0.51
3.8
3.7
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
16
122
1.33
0.43
1.8
2.7
g/l
2.9
3.3
—
8
99
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
16
122
1.33
0.43
2.0
2.0
%
1.5
1.6
0.41
11
101
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
22
177
1.26
0.41
1.2
1.4
—
—
—
0
0
(4268621)
0
15
0.00
0.41
0.0
2.0
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
0
16
0.00
0.41
0.0
1.2
—
30.3
—
0
10
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
0
16
0.00
0.41
0.0
1.1
—
104.0
—
0
5
(3014765) Yersinia sp identified in Stool by Organism specific culture
10
71
1.42
0.39
1.2
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
9
67
1.35
0.38
2.8
2.3
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
15
116
1.31
0.37
1.9
2.8
g/l
0.0
0.7
—
8
100
(3024928) Oxygen saturation in Venous blood
9
69
1.31
0.37
2.0
1.9
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
10
72
1.40
0.37
1.2
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
9
71
1.28
0.36
1.2
1.1
—
—
—
0
0
(3026782) Osmolality of Urine
51
570
0.87
0.35
3.1
2.8
mosm/kgh2o
510.8
541.6
0.41
43
478
(1616796) Gas panel - Central venous blood
6
43
1.40
0.35
8.8
3.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
44
1.37
0.34
1.3
1.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
125
1178
1.10
0.34
5.2
4.1
estimate
0.0
0.0
0.00
14
228
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
14
109
1.30
0.34
1.9
2.3
g/l
38.7
36.4
—
8
95
(1761482) Bacteria [#/volume] in Urine by Culture
12
92
1.32
0.32
4.1
5.5
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
7
52
1.35
0.31
2.3
1.7
%
61.1
59.5
—
7
52
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
7
52
1.35
0.31
1.3
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
7
55
1.28
0.30
1.1
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8
63
1.28
0.28
2.5
2.0
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
20
168
1.20
0.28
5.2
3.6
%
0.3
0.2
0.22
11
43
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
8
64
1.26
0.27
1.1
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
8
64
1.26
0.27
1.1
1.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
21
178
1.19
0.27
5.0
3.6
%
1.6
1.0
—
10
47
(40760892) CBC W Ordered Manual Differential panel - Blood
34
381
0.88
0.25
5.4
4.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
9
73
1.24
0.25
1.3
1.3
—
—
—
0
0
(3012544) pH of Venous blood
33
294
1.14
0.24
3.5
3.1
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
5
38
1.32
0.23
4.6
3.6
u/ml
40.6
61.0
—
5
38
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
39
1.29
0.23
1.2
1.2
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
14
116
1.22
0.22
1.1
2.1
g/l
1.0
1.7
0.85
14
102
(4035726)
27
239
1.14
0.22
1.3
1.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(44813793)
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
12
0.00
0.21
0.0
2.8
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
12
0.00
0.21
0.0
2.8
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
72.5
—
0
6
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
24.0
—
0
5
(3038515) Glucose [Moles/volume] in Venous blood
10
80
1.26
0.20
3.7
2.9
mmol/l
8.0
7.9
—
10
80
(3024263) Appearance of Synovial fluid
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
6
50
1.20
0.20
2.2
2.3
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
6
52
1.16
0.19
1.8
2.5
%
77.5
88.1
—
6
52
(3008037) Lactate [Moles/volume] in Venous blood
10
81
1.24
0.19
3.7
2.9
mmol/l
1.7
1.6
—
10
81
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
33
300
1.11
0.18
4.3
3.1
ug/l
1.0
0.9
0.34
24
213
(4094501)
7
58
1.21
0.18
1.3
1.1
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
8
68
1.18
0.16
2.9
2.4
mmol/l
26.8
25.8
—
8
53
(3000991) Gas panel - Venous blood
20
223
0.89
0.15
7.8
7.6
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
8
96
0.83
0.14
2.5
2.4
g/l
0.0
0.0
—
8
88
(3021601) Nitrite [Presence] in Urine by Test strip
120
1168
1.04
0.12
7.8
5.5
estimate
0.0
0.0
0.00
14
226
(3000330) Specific gravity of Urine by Test strip
14
156
0.89
0.10
3.9
4.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
17
154
1.11
0.10
5.9
3.9
%
0.7
2.9
—
9
33
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
16
145
1.11
0.09
2.8
2.0
%
1.1
1.0
0.15
16
145
(3015171) Extractable nuclear Ab [Units/volume] in Serum
6
56
1.07
0.08
1.0
1.2
—
0.3
—
0
5
(3010421) pH of Blood
6
58
1.04
0.08
9.7
2.5
ph
7.4
7.4
—
6
45
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
62
0.80
0.08
1.0
1.2
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
7
65
1.08
0.08
2.0
2.3
kpa
8.7
7.8
—
7
55
(3019832) Treponema pallidum Ab [Presence] in Serum
6
74
0.81
0.07
2.5
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
8
75
1.07
0.07
2.0
3.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
8
76
1.05
0.07
1.0
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
21
198
1.07
0.05
3.3
3.8
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
17
161
1.06
0.03
5.5
3.7
%
0.8
0.5
—
9
32
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
86
854
1.01
0.00
5.6
4.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
52
518
1.00
0.00
1.2
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
16
163
0.98
0.00
1.4
1.5
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
27
265
1.02
0.00
3.0
2.6
g/l
65.2
65.8
0.19
21
241
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
17.6
—
0
5
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
145.0
—
0
5
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
3.9
—
0
5
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
8.4
—
127.2
—
0
5
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
5
0.00
0.00
0.0
1.6
—
3694.2
—
0
5
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
5
0.00
0.00
0.0
18.2
—
5.4
—
0
5
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
9
90
1.00
0.00
2.6
2.4
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
5
52
0.96
0.00
3.2
2.5
mmol/l
103.6
105.3
—
5
52
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
52
0.96
0.00
3.2
2.5
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
6.3
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
6
0.00
0.00
0.0
4.3
—
57.3
—
0
6
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.7
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
5
52
0.96
0.00
3.2
2.5
mmol/l
3.9
4.0
—
5
52
(3002032) Base excess in Venous blood by calculation
29
290
1.00
0.00
3.8
3.0
mmol/l
2.8
2.1
0.67
23
226
(3005033) Fetal Nuchal fold Thickness US
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
0
7
0.00
0.00
0.0
1.0
—
102.6
—
0
7
(3033799) Differential panel - Peritoneal fluid
0
7
0.00
0.00
0.0
3.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
6
0.00
0.00
0.0
4.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
5
52
0.96
0.00
1.4
1.6
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(43055442) Apixaban [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
209.2
—
0
6
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
9.8
—
0
9

Mortality – FinRegistry

Association

Association between endpoint H7_DISORDERLENSNAS and mortality.

Females

Parameter HR [95% CI] p-value
H7_DISORDERLENSNAS 0.822 [0.71, 0.95] 0.008
Birth year 0.991 [0.98, 1.0] 0.045

During the follow-up period (1.1.1998 — 31.12.2019), 396 out of 1446 females with H7_DISORDERLENSNAS died.

Males

Parameter HR [95% CI] p-value
H7_DISORDERLENSNAS 0.896 [0.71, 1.13] 0.349
Birth year 0.987 [0.98, 1.0] 0.038

During the follow-up period (1.1.1998 — 31.12.2019), 167 out of 496 males with H7_DISORDERLENSNAS died.

Mortality risk

Mortality risk for people of age

years, who have H7_DISORDERLENSNAS.

N-year risk Females Males
1 0.07% 0.164%
5 0.401% 1.067%
10 1.029% 2.606%
15 1.935% 5.137%
20 3.429% 8.56%

Relationships between endpoints

Index endpoint: H7_DISORDERLENSNAS – Other specified and unspecified disorders of lens

GWS hits: 2

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data